Multi-institute study finds many men with prostate cancer can avoid early surgery
- Posted: July 19, 2012
New research suggests that many men with prostate cancer do not need immediate treatment, especially if they have low PSA scores or low-risk tumors that are unlikely to grow and spread. The multi-center study, published July 18 in the New England Journal of Medicine, compared prostate cancer surgery soon after diagnosis to observation in men with early-stage prostate tumors detected by PSA screening. Overall, most men did not benefit from surgery – it did not reduce the likelihood they would die from prostate cancer or other causes. The study included researchers from the Baylor College of Medicine (home to the Dan L. Duncan Cancer Center), the Siteman Cancer Center at Washington University School of Medicine, and the Minneapolis Veterans Administration Health Care System.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.